• Biogen Idec (NASDAQ:BIIB) posted better-than-estimated fourth quarter results of $1.20, beating Zacks estimates of $1.05, on inline revenues of $1.1 billion.  The company said it sees full year earnings of $4.50 a share

• International Flavors and Fragrances (NYSE:IFF) reported fourth quarter results of 63 cents, three cents better than Zacks estimates, on sales of $586 million, versus Zacks estimates of $572 million

• Molson Coors (NYSE:TAP) released fourth quarter results of $1.02, below Zacks estimates of $1.09

• Coventry Health (NYSE:CVH) announced fourth quarter earnings of 74 cents, above Zacks estimates of 56 cents, on inline revenues of $3.4 billion

• NYSE Euronext (NYSE:NYX) reported better-than-expected results of 58 cents, versus Zacks estimates of 48 cent estimates on revenues of 640 million, versus Zacks estimates of $637 million

• Bernstein upgraded Verizon (NYSE:VZ) to “overweight”

• Bank of America (NYSE:BAC) upgraded Monsanto (NYSE:MON) to “buy” with a price target of $96

• SAP (NYSE:SAP) was upgraded from “underweight” to “market weight” by analysts at FBR, with a price target of $44

• Royal Dutch Shell (NYSE:RDS) received an upgrade from “underweight” to “overweight” by analysts at HSBC (NYSE:HBC)

Zacks Investment Research